Published in J Gen Microbiol on December 01, 1977
Characterization of non-beta-lactamase-mediated ampicillin resistance in Haemophilus influenzae. Antimicrob Agents Chemother (1984) 4.25
Characterization of chloramphenicol-resistant Haemophilus influenzae. Antimicrob Agents Chemother (1980) 2.07
Transferable antibiotic resistance elements in Haemophilus influenzae share a common evolutionary origin with a diverse family of syntenic genomic islands. J Bacteriol (2004) 1.93
A permeability barrier as a mechanism of chloramphenicol resistance in Haemophilus influenzae. Antimicrob Agents Chemother (1985) 1.84
Molecular nature of two Haemophilus influenzae R factors containing resistances and the multiple integration of drug resistance transposons. J Bacteriol (1979) 1.66
Molecular nature of a plasmid specifying beta-lactamase production in Haemophilus ducreyi. J Bacteriol (1981) 1.24
Molecular characterization of "plasmid-free" antibiotic-resistant Haemophilus influenzae. J Bacteriol (1980) 1.20
Characterization of ampicillin resistance plasmids from Haemophilus ducreyi. Antimicrob Agents Chemother (1982) 1.19
Origin of Haemophilus influenzae R factors. J Bacteriol (1981) 1.02
Integration of plasmid DNA coding for beta-lactamase production in the Haemophilus influenzae chromosome. J Bacteriol (1984) 0.89
The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear beta-1,6-linked glucosaminoglycan: purification and structural analysis. J Bacteriol (1996) 5.82
Genetically manipulated virulence of Yersinia enterocolitica. Infect Immun (1984) 3.81
A plasmid of enterohemorrhagic Escherichia coli O157:H7 is required for expression of a new fimbrial antigen and for adhesion to epithelial cells. Infect Immun (1987) 3.76
Parallel induction by glucose of adherence and a polysaccharide antigen specific for plastic-adherent Staphylococcus epidermidis: evidence for functional relation to intercellular adhesion. Infect Immun (1992) 3.68
Double immunofluorescence microscopic technique for accurate differentiation of extracellularly and intracellularly located bacteria in cell culture. J Clin Microbiol (1985) 2.72
Immunochemical analysis of plasmid-encoded proteins released by enteropathogenic Yersinia sp. grown in calcium-deficient media. Infect Immun (1986) 2.42
Construction of a mobilizable Yersinia enterocolitica virulence plasmid. J Bacteriol (1983) 2.33
20-fold increase in risk of lamivudine resistance in hepatitis B virus subtype adw. Lancet (2001) 2.32
Vertical transmission of hepatitis G. Lancet (1996) 2.23
Plasmids of human strains of Yersinia enterocolitica: molecular relatedness and possible importance for pathogenesis. J Infect Dis (1983) 2.20
Detection of Campylobacter pyloridis in patients with antrum gastritis and peptic ulcers by culture, complement fixation test, and immunoblot. J Clin Microbiol (1986) 1.85
Phage-associated cytotoxin production by and enteroadhesiveness of enteropathogenic Escherichia coli isolated from infants with diarrhea in West Germany. J Infect Dis (1987) 1.79
Association of biofilm production of coagulase-negative staphylococci with expression of a specific polysaccharide intercellular adhesin. J Infect Dis (1996) 1.72
Molecular nature of two Haemophilus influenzae R factors containing resistances and the multiple integration of drug resistance transposons. J Bacteriol (1979) 1.66
Minimal effect of delayed sample processing on results of quantitative PCR for cytomegalovirus DNA in leukocytes compared to results of an antigenemia assay. J Clin Microbiol (1997) 1.54
Essential functional role of the polysaccharide intercellular adhesin of Staphylococcus epidermidis in hemagglutination. Infect Immun (1999) 1.51
Molecular characterization of a small Haemophilus influenzae plasmid specifying beta-lactamase and its relationship to R factors from Neisseria gonorrhoeae. J Gen Microbiol (1979) 1.38
Study on reliability of commercially available hepatitis C virus antibody tests. J Clin Microbiol (1995) 1.34
Mycobacterium microti llama-type infection presenting as pulmonary tuberculosis in a human immunodeficiency virus-positive patient. J Clin Microbiol (2001) 1.30
Susceptibility to Herpesvirus saimiri and antibody development in old and new world monkeys. Med Microbiol Immunol (1973) 1.26
Lack of mecA transcription in slime-negative phase variants of methicillin-resistant Staphylococcus epidermidis. Antimicrob Agents Chemother (1994) 1.21
Virulence factors of Enterococcus faecalis and Enterococcus faecium blood culture isolates. Eur J Clin Microbiol Infect Dis (2000) 1.21
False-positive results of plasma PCR for cytomegalovirus DNA due to delayed sample preparation. J Clin Microbiol (2000) 1.21
Molecular properties of transmissible R factors of Haemophilus influenzae determing tetracycline resistance. J Gen Microbiol (1978) 1.19
Studies on the substructure of togaviruses. II. Analysis of equine arteritis, rubella, bovine viral diarrhea, and hog cholera viruses. Arch Gesamte Virusforsch (1971) 1.17
Generalized transduction for genetic linkage analysis and transfer of transposon insertions in different Staphylococcus epidermidis strains. Zentralbl Bakteriol (1998) 1.16
High percentage of seronegative HCV infections in hemodialysis patients: the need for PCR. Intervirology (1997) 1.13
HIV-infection in forensic autopsy cases. Forensic Sci Int (1987) 1.09
Early infections in patients undergoing bone marrow or blood stem cell transplantation--a 7 year single centre investigation of 409 cases. Bone Marrow Transplant (1999) 1.08
Quantitative detection of hepatitis C virus RNA by light cycler PCR and comparison with two different PCR assays. J Clin Microbiol (2001) 1.08
Prevalence of hepatitis G viremia among healthy subjects, individuals with liver disease, and persons at risk for parenteral transmission. J Clin Microbiol (1997) 1.08
Origin of Haemophilus influenzae R factors. J Bacteriol (1981) 1.02
Amplification of resistance genes in Haemophilus influenzae plasmids. J Bacteriol (1983) 1.02
Characterization of different oligomeric species of the Yersinia enterocolitica outer membrane protein YadA. Med Microbiol Immunol (1994) 0.99
Self-limited traveller's diarrhea due to a dual infection with Enterocytozoon bieneusi and Cryptosporidium parvum in an immunocompetent HIV-negative child. Eur J Clin Microbiol Infect Dis (1995) 0.99
Distribution of hepatitis G viremia and antibody response to recombinant proteins with special regard to risk factors in 709 patients. Hepatology (1997) 0.98
Postmortem viability of the human immunodeficiency virus. Int J Legal Med (1991) 0.96
Primary genotypic resistance of HIV-1 to the fusion inhibitor T-20 in long-term infected patients. AIDS (2001) 0.96
Utility of major leukocyte subpopulations for monitoring secondary cytomegalovirus infections in renal-allograft recipients by PCR. J Clin Microbiol (1998) 0.96
Acute and long-term humoral immunity following active immunization of rabbits with inactivated spores of various Encephalitozoon species. Parasitol Res (2001) 0.95
Detection of TT virus DNA and GB virus type C/Hepatitis G virus RNA in serum and breast milk: determination of mother-to-child transmission. J Clin Microbiol (2000) 0.95
Nonstructural protein 3 of hepatitis C virus blocks the distribution of the free catalytic subunit of cyclic AMP-dependent protein kinase. J Virol (1997) 0.95
Non-structural protein 3 of hepatitis C virus inhibits phosphorylation mediated by cAMP-dependent protein kinase. Eur J Biochem (1996) 0.94
Area under the viraemia curve versus absolute viral load: utility for predicting symptomatic cytomegalovirus infections in kidney transplant patients. J Med Virol (2001) 0.93
Serological determination of hepatitis C virus subtypes 1a, 1b, 2a, 2b, 3a, and 4a by a recombinant immunoblot assay. J Clin Microbiol (1999) 0.93
Relevance of reactivity in commercially available hepatitis C virus antibody assays. J Clin Microbiol (2001) 0.93
Tear fluid of hepatitis C virus carriers could be infectious. J Clin Microbiol (1995) 0.92
Definition of false-positive reactions in screening for hepatitis C virus antibodies. J Clin Microbiol (1999) 0.92
Comparison of three HCV genotyping assays: a serological method as a reliable and inexpensive alternative to PCR based assays. J Clin Virol (2001) 0.91
Greater amount of HCV-RNA in tears compared to blood. Microbiol Immunol (1994) 0.90
Serological response to type 1-like somatic fimbriae in diarrheal infection due to classical enteropathogenic Escherichia coli. Microb Pathog (1987) 0.89
Prevalence and clinical significance of intestinal microsporidiosis in human immunodeficiency virus-infected patients with and without diarrhea in Germany: a prospective coprodiagnostic study. Clin Infect Dis (1998) 0.89
Prevalence of SENV-H viraemia among healthy subjects and individuals at risk for parenterally transmitted diseases in Germany. J Viral Hepat (2002) 0.89
Malignant lymphoma induced by partially purified Herpesvirus saimiri and recovery of infectious virus from tumorous lymph nodes. Med Microbiol Immunol (1972) 0.89
Prevalence, incidence, and clinical relevance of the reverse transcriptase V207I mutation outside the YMDD motif of the hepatitis B virus polymerase during lamivudine therapy. J Clin Microbiol (2005) 0.88
Transposon mutagenesis in Staphylococcus epidermidis using the Enterococcus faecalis transposon Tn917. FEMS Microbiol Lett (1991) 0.88
Catalase-negative Listeria monocytogenes causing lethal sepsis and meningitis in an adult hematologic patient. Eur J Clin Microbiol Infect Dis (1996) 0.88
Comparison of conventional autoradiography with a new DNA enzyme immunoassay for the detection of hepatitis C virus-polymerase chain reaction amplification products. J Virol Methods (1995) 0.88
Close correlation between hepatitis C virus serology and polymerase chain reaction in chronically infected patients. Infection (1993) 0.88
The influence of age on the prevalence of hepatitis C virus subtypes 1a and 1b. J Infect Dis (1997) 0.86
Latent infection and malignant lymphoma in marmosets (Callithrix jacchus) after infection with two oncogenic herpesviruses from primates. J Natl Cancer Inst (1974) 0.86
Identification and characterization of a histone binding site of the non-structural protein 3 of hepatitis C virus. J Clin Virol (1999) 0.86
Characterization of genes specifying ampicillin resistance in bacterial isolates using a single-strand specific nuclease for analysis of plasmid DNA-DNA duplexes. J Gen Microbiol (1979) 0.86
Intra-articular empyema due to Staphylococcus caprae following arthroscopic cruciate ligament repair. J Infect (1998) 0.86
[Hepatitis A, B and C as desmoteric infections]. Gesundheitswesen (1993) 0.86
Systemic Penicillium marneffei infection in a German AIDS patient. Eur J Clin Microbiol Infect Dis (1996) 0.86
Vaccination of non-human primates against malignant lymphoma. Nature (1975) 0.85
Plasmid-mediated formaldehyde resistance in Escherichia coli: characterization of resistance gene. Antimicrob Agents Chemother (1996) 0.85
Low risk of vertical transmission of hepatitis C virus by breast milk. Clin Infect Dis (1999) 0.85
A comparative study of the in vitro antimicrobial activity of tea tree oils s.l. with special reference to the activity of beta-triketones. Planta Med (2000) 0.85
Experience with quantitative PCR for the management of HCMV disease. Intervirology (1996) 0.85
Circularized copies of amplifiable resistance genes from Haemophilus influenzae plasmids. J Bacteriol (1983) 0.85
Nosocomial infections by Listeria monocytogenes: analysis of a cluster of septicemias in immunocompromised patients. Infection (1997) 0.84
Strategies for reliable diagnosis of hepatitis C infection: the need for a serological confirmatory assay. J Med Virol (2001) 0.84
Correlation of hepatitis B virus load with loss of e antigen and emerging drug-resistant variants during lamivudine therapy. J Med Virol (2001) 0.84
Hepatitis C virus infection in pregnancy and the risk of mother-to-child transmission. Eur J Clin Microbiol Infect Dis (1997) 0.84
Polymerase chain reaction (PCR) from ficoll-purified polymorphonuclear leukocytes for monitoring cytomegalovirus infections in renal allograft recipients: superior sensitivity and similar specificity compared with plasma PCR. J Infect Dis (1998) 0.84
Inter- and intra-species karyotype variations among microsporidia of the genus Encephalitozoon as determined by pulsed-field gel electrophoresis. Scand J Infect Dis (1999) 0.83
Microenzyme-linked immunosorbent assay for the detection of specific IgM antibodies in human syphilis. Br J Vener Dis (1983) 0.83
High rate of chronicity in HCV infection determined by antibody confirmatory assay and PCR in 4110 patients during long-term follow-up. J Clin Virol (1999) 0.83
Regulation of epidermal growth factor receptor kinase activity by polyions. J Biochem (1994) 0.83
Construction of a slime negative transposon mutant in Staphylococcus epidermidis using the Enterococcus faecalis transposon Tn917. Microbiol Immunol (1993) 0.83
Fatal pulmonary hemorrhage in patients with acute leukemia and fulminant pneumonia caused by Stenotrophomonas maltophilia. Ann Hematol (1997) 0.83
[Inhibition of rubella virus hemagglutination. I. Properties of an inhibitor of rubella virus hemagglutination in vitro present in fetal calf serum]. Arch Gesamte Virusforsch (1968) 0.82
Variable degree of slime production is linked to different levels of beta-lactam susceptibility in Staphylococcus epidermidis phase variants. Med Microbiol Immunol (1995) 0.82
Formaldehyde-resistance in Enterobacteriaceae and Pseudomonas aeruginosa: identification of resistance genes by DNA-hybridization. Zentralbl Hyg Umweltmed (1991) 0.82
Drug-resistant genotyping in HIV-1 therapy. Lancet (1999) 0.81
Characterisation of non-structural protein 3 of hepatitis C virus as modulator of protein phosphorylation mediated by PKA and PKC: evidences for action on the level of substrate and enzyme. Arch Virol (1999) 0.81
Oncogenicity of Herpesvirus ateles in monkeys. J Natl Cancer Inst (1973) 0.81
Hepatitis B e-antigen titres for evaluating infectivity during hepatitis B virus infection. Klin Wochenschr (1984) 0.81
Disseminated Encephalitozoon (Septata) intestinalis infection in a patient with AIDS: novel diagnostic approaches and autopsy-confirmed parasitological cure following treatment with albendazole. J Clin Microbiol (1995) 0.80
[Prevalence of Borrelia burgdorferi antibodies in Hamburg blood donors]. Beitr Infusionsther (1992) 0.80
Seroconversion for hepatitis C virus antibody in bone marrow recipients treated with immune globulin. N Engl J Med (1991) 0.80
[Comparative studies on the rotavirus syndrome following infection with human rotavirus of the subgroup 1 or 2]. Monatsschr Kinderheilkd (1984) 0.80
Vaccination of nonhuman primates with killed oncogenic herpesviruses. Cancer Res (1976) 0.80